NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 39 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,786 | -12.8% | 14,200 | -46.5% | 0.00% | – |
| Q4 2022 | $13,517 | -89.8% | 26,556 | -79.4% | 0.00% | – |
| Q2 2022 | $133,000 | -19.9% | 129,119 | +46.1% | 0.00% | – |
| Q1 2022 | $166,000 | -88.3% | 88,400 | -69.9% | 0.00% | – |
| Q4 2021 | $1,416,000 | +159.8% | 293,512 | +290.1% | 0.00% | – |
| Q3 2021 | $545,000 | -58.6% | 75,240 | -47.2% | 0.00% | – |
| Q2 2021 | $1,316,000 | -17.3% | 142,623 | +10.3% | 0.00% | – |
| Q1 2021 | $1,592,000 | -54.5% | 129,316 | -47.8% | 0.00% | – |
| Q4 2020 | $3,496,000 | +629.9% | 247,836 | +521.0% | 0.00% | – |
| Q3 2020 | $479,000 | +40.9% | 39,911 | +94.7% | 0.00% | – |
| Q2 2020 | $340,000 | -25.4% | 20,500 | -48.9% | 0.00% | – |
| Q1 2020 | $456,000 | -54.9% | 40,100 | -51.1% | 0.00% | – |
| Q4 2019 | $1,010,000 | – | 82,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,225,000 | $15,080,000 | 2.22% |
| EcoR1 Capital, LLC | 3,122,704 | $38,440,000 | 1.70% |
| Redmile Group, LLC | 4,117,569 | $50,687,000 | 0.71% |
| HighVista Strategies LLC | 71,235 | $877,000 | 0.65% |
| Boxer Capital, LLC | 1,501,058 | $18,478,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $47,046,000 | 0.20% |
| Sio Capital Management, LLC | 38,312 | $472,000 | 0.10% |
| Highland Private Wealth Management | 46,999 | $579,000 | 0.10% |
| Point72 Asset Management, L.P. | 1,308,600 | $16,109,000 | 0.08% |
| Granahan Investment Management | 200,518 | $2,468,000 | 0.05% |